PHARMACOKINETIC AND CONCENTRATION-EFFECT STUDIES WITH INTRAVENOUS METOCLOPRAMIDE

被引:92
作者
BATEMAN, DN
KAHN, C
MASHITER, K
DAVIES, DS
机构
[1] ROYAL POSTGRAD MED SCH,DEPT CLIN PHARMACOL,LONDON W12 0HS,ENGLAND
[2] ROYAL POSTGRAD MED SCH,DEPT MED,LONDON W12 0HS,ENGLAND
关键词
D O I
10.1111/j.1365-2125.1978.tb04604.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:401 / 407
页数:7
相关论文
共 22 条
[1]  
AHTEE L, 1975, BRIT J PHARMACOL, V55, P381, DOI 10.1111/j.1476-5381.1975.tb06941.x
[2]   ABSORPTION AND ELIMINATION OF METOCLOPRAMIDE IN 3 ANIMAL SPECIES [J].
BAKKE, OM ;
SEGURA, J .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1976, 28 (01) :32-39
[3]  
BARBORIAK JJ, 1970, AM J CLIN NUTR, V23, P1151
[4]   NON-INVASIVE TECHNIQUE FOR GASTRIC MOTILITY MEASUREMENT [J].
BATEMAN, DN ;
LEEMAN, S ;
METREWELI, C ;
WILLSON, K .
BRITISH JOURNAL OF RADIOLOGY, 1977, 50 (595) :526-527
[5]   IDENTIFICATION OF 4 NEW METABOLIC PRODUCTS OF METOCLOPRAMIDE USING MASS-SPECTROMETRY [J].
COWAN, DA ;
HUIZING, G ;
BECKETT, AH .
XENOBIOTICA, 1976, 6 (10) :605-616
[6]  
DAVIES DS, 1977, CLIN PHARMACOL THER, V21, P593
[7]  
DONALDSON IM, 1976, BRIT J PHARMACOL, V56, pP373
[8]   METOCLOPRAMIDE AS A DOPAMINE ANTAGONIST IN HEART AND GUT OF MOLLUSK TAPES-WATLINGI [J].
DOUGAN, DFH ;
MEARRICK, PT ;
WADE, DN .
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1974, 1 (06) :473-478
[9]  
EISNER M, 1971, DIGESTIVE DISEASES, V16, P409
[10]   ASSESSMENT OF GASTRIC-EMPTYING BY BREATHALYSER [J].
FINCH, JE ;
KENDALL, MJ ;
MITCHARD, M .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1974, 1 (03) :233-236